Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Securities and Exchange Commission
Biotech
Cassava pays $40M over allegedly misleading Alzheimer's update
The charges include the accusation that a former Cassava exec removed 40% of the participants from an analysis of the episodic memory results.
Nick Paul Taylor
Sep 27, 2024 9:20am
Allarity warned of pending SEC charges over FDA meeting conduct
Jul 22, 2024 9:50am
SEC joins DOJ in charging Stimwave ex-CEO with fraud
Dec 21, 2023 12:17pm
Man accused of insider trading tied to Pfizer's Array purchase
Oct 19, 2023 10:22am
SEC to probe Illumina acquisition amid Grail deal fallout
Aug 11, 2023 10:41am
Philips inks $62M SEC settlement over selling practices in China
May 15, 2023 10:30am
